Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and ...

With next-generation digital PET-CT scanners, AI-powered imaging, and integrated pathology support, we are empowering clinicians with the precision tools needed for early, accurate detection and ...

The drug is not being tested for any other indications, although it has been mooted as a potential treatment for severe acne and/or sebaceous hyperplasia, as well as Darier disease, a rare ...

81-year-old female with a remote history of follicular lymphoma was undergoing evaluation for possible disease recurrence when an incidental right breast mass was identified. 51-year-old female ...

You’re on the couch, cozied up with your canine buddy, and you feel a bump. You try to remember when you last nuzzled this exact little spot. And before you know it, your mind is racing with ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Spokane Valley-based Incyte Diagnostics has agreed to sell select assets of its clinical and anatomic pathology testing businesses to Burlington, North Carolina-based Labcorp (NYSE: LH). The assets ...

On May 8, 2025, Neurocrine Biosciences announced new results from subgroup analyses of its phase 3 CAHtalyst pediatric study evaluating crinecerfont (CRENESSITY; Neurocrine Biosciences) in children ...

We are committed to providing the highest quality patient care while advancing research and education in orthopedics, rheumatology, and related disciplines, including musculoskeletal pathology. The ...

Clinical Review: Benign prostatic hyperplasia How to assess, diagnose and manage BPH in primary care. By Mr Altaf Mangera and Mr Christopher Chapple ...